Prevalence and clinical correlates of anti‐phospholipid antibodies in South Africans with systemic lupus erythematosus

References

• Marai I., Zandman‐Goddard G., Shoenfeld Y. The systemic nature of the antiphospholipid syndrome. Scand J Rheumatol 2004; 33: 365–72
   PubMed Web of Science ®Google Scholar
• Wilson W. A., Gharavi A. E., Koike T., Lockshin M. D., Branch D. W., Piette J. C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309–11
   PubMed Web of Science ®Google Scholar
• Marai I., Tincani A., Balestrieri G., Shoenfeld Y. Anticardiolipin and anti‐beta‐2‐glycoprotein I antibodies. Autoimmunity 2005; 38: 33–8
   PubMed Web of Science ®Google Scholar
• Petri M. Clinical and management aspects of the antiphospholipid antibody syndrome. Dubois' lupus erythematosus 6, D. J Wallace, B. H Hahn. Lea and Febiger, Philadelphia 2000; 1093–128
   Google Scholar
• Bertolaccini M. L., Atsumi T., Escudero Contreras A., Khamashta M. A., Hughes G. R. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. J Rheumatol 2001; 28: 2637–43
   PubMed Web of Science ®Google Scholar
• Bertolaccini M. L., Roch B., Amengual O., Atsumi T., Khamashta M. A., Hughes G. R. Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome. Br J Rheumatol 1998; 37: 1229–32
   PubMedGoogle Scholar
• Munoz‐Rodriguez F. J., Reverter J. C., Font J., Tassies D., Cervera R., Espinosa G., et al. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. Haematologica 2000; 85: 632–7
   PubMedGoogle Scholar
• Galli M., Lucani D., Bertolini G., Barbui T. Anti‐beta 2‐glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003; 102: 2717–23
   PubMed Web of Science ®Google Scholar
• Mody G. M., Parag K. B., Nathoo B. C., Pudifin D. J., Duursma J., Seedat Y. K. High mortality with systemic lupus erythematosus in hospitalized African blacks. Br J Rheumatol 1994; 33: 1151–3
   PubMedGoogle Scholar
• Tikly M., Burgin S., Mohanlal P., Bellingan A., George J. Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations. Clin Rheumatol 1996; 15: 261–5
   PubMedGoogle Scholar
• Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
   PubMed Web of Science ®Google Scholar
• Loizou S., Singh S., Wypkema E., Asherson R. A. Anticardiolipin, anti‐beta(2)‐glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum Dis 2003; 62: 1106–11
   PubMedGoogle Scholar
• Bombardier C., Gladman D. D., Urowitz M. B., Caron D., Chang C. H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630–40
   PubMed Web of Science ®Google Scholar
• Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363–9
   PubMed Web of Science ®Google Scholar
• Cucurull E., Gharavi A. E., Diri E., Mendez E., Kapoor D., Espinoza L. R. IgA anticardiolipin and anti‐beta2‐glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus. Am J Med Sci 1999; 318: 55–60
   PubMed Web of Science ®Google Scholar
• O'Neill A. I., Ibrahim K. M., Des Parkin J. Automation of the kaolin clotting time. Pathology 1992; 24: 12–14
   PubMed Web of Science ®Google Scholar
• Molina J. F., Gutierrez‐Urena S., Molina J., Uribe O., Richards S., De Ceulaer C., et al. Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 291–6
   PubMed Web of Science ®Google Scholar
• Faghiri Z., Wilson W. A., Taheri F., Barton E. N., Morgan O. S., Gharavi A. E. Antibodies to cardiolipin and beta2‐glycoprotein‐1 in HTLV‐1‐associated myelopathy/tropical spastic paraparesis. Lupus 1999; 8: 210–14
   PubMedGoogle Scholar
• Lopez L. R., Santos M. E., Espinoza L. R., La Rosa F. G. Clinical significance of immunoglobulin A versus immunoglobulins G and M anti‐cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion. Am J Clin Pathol 1992; 98: 449–54
   PubMedGoogle Scholar
• Cuadrado M. J., Tinahones F., Camps M. T., de Ramon E., Gomez‐Zumaquero J. M., Mujic F., et al. Antiphospholipid, anti‐beta 2‐glycoprotein‐I and anti‐oxidized‐low‐density‐lipoprotein antibodies in antiphospholipid syndrome. Q J Med 1998; 91: 619–26
   Google Scholar
• Lynch A., Byers T., Emlen W., Rynes D., Shetterly S. M., Hamman R. F. Association of antibodies to beta2‐glycoprotein 1 with pregnancy loss and pregnancy‐induced hypertension: a prospective study in low‐risk pregnancy. Obstet Gynecol 1999; 93: 193–8
   PubMedGoogle Scholar
• Lee R. M., Emlen W., Scott J. R., Branch D. W., Silver R. M. Anti‐beta2‐glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome. Am J Obstet Gynecol 1999; 181: 642–8
   PubMedGoogle Scholar
• Bruce I. N., Clark‐Soloninka C. A., Spitzer K. A., Gladman D. D., Urowitz M. B., Laskin C. A. Prevalence of antibodies to beta2‐glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. J Rheumatol 2000; 27: 2833–7
   PubMedGoogle Scholar
• von Landenberg P., Matthias T., Zaech J., Schultz M., Lorber M., Blank M., et al. Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. Am J Reprod Immunol 2003; 49: 51–56
   PubMedGoogle Scholar
• Galli M., Barbui T. Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome. Blood 1999; 93: 2149–57
   PubMedGoogle Scholar
• Galli M. Should we include anti‐prothrombin antibodies in the screening for the antiphospholipid syndrome?. J Autoimmun 2000; 15: 101–5
   PubMed Web of Science ®Google Scholar
• Swadzba J., De Clerck L. S., Stevens W. J., Bridts C. H., van Cotthem K. A., Musial J., et al. Anticardiolipin, anti‐beta(2)‐glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheumatol 1997; 24: 1710–15
   PubMed Web of Science ®Google Scholar
• Salcido‐Ochoa F., Cabiedes J., Alarcon‐Segovia D., Carbral A. R. Anti‐prothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. J Clin Rheumatol 2002; 8: 251–5
   PubMedGoogle Scholar
• Cervera R., Asherson R. A. Clinical and epidemiological aspects in the antiphospholipid syndrome. Immunobiology 2003; 207: 5–11
   PubMed Web of Science ®Google Scholar
• Avcin T., Ambrozic A., Bozic B., Accetto M., Kveder T., Rozman B. Estimation of anticardiolipin antibodies, anti‐beta2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis. Clin Exp Rheumatol 2002; 20: 101–8
   PubMed Web of Science ®Google Scholar
• Out H. J., de Groot P. G., Hasselaar P., dan Vliet M., Derksen R. H. Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis 1989; 48: 1023–8
   PubMedGoogle Scholar
• Perez‐Vazquez M. E., Villa A. R., Drenkard C., Cabiedes J., Alarcon‐Segovia D. Influence of disease duration, continued followup and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus. J Rheumatol 1993; 20: 437–42
   PubMedGoogle Scholar